Publications by authors named "Chirantan Chatterjee"

Claim this Profile
F
Factors determining compliance with recommended intravitreal injections for retinal diseases among out-of-pocket, fully subsidized (non-paying), and insured patients: Real-world evidence from India.
Anthony V Das, Brijesh Kashyap, Brijesh Takkar, Ragukumar Venugopal, Chirantan Chatterjee

Indian J Ophthalmol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can AI predict and limit online hate?
Chirantan Chatterjee

Nature· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial vulnerability of the elderly population undergoing cataract surgery within a distributed eye care delivery system in India (2011-2022): a multicentre, retrospective cohort study.
Brijesh Takkar, Ragukumar Venugopal, Mehul Mehta, Anthony Vipin Das, Varsha Rathi, Chirantan Chatterjee

Lancet Reg Health Southeast Asia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Movies, stigma and choice: Evidence from the pharmaceutical industry.
Mayank Aggarwal, Anindya S Chakrabarti, Chirantan Chatterjee

Health Econ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pandemics and technology engagement: New evidence from m-Health intervention during COVID-19 in India.
Sawan Rathi, Anindya S Chakrabarti, Chirantan Chatterjee, Aparna Hegde

Rev Dev Econ· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling.
Matthew J Higgins, Xin Yan, Chirantan Chatterjee

Res Policy· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Did India's price control policy for coronary stents create unintended consequences?
Sarang Deo, Hanu Tyagi, Chirantan Chatterjee, Himasagar Molakapuri

Soc Sci Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From courts to markets: New evidence on enforcement of pharmaceutical bans in India.
Chirantan Chatterjee, Debi Prasad Mohapatra, Manuel Estay

Soc Sci Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Government health insurance and spatial peer effects: New evidence from India.
Chirantan Chatterjee, Radhika Joshi, Neeraj Sood, P Boregowda

Soc Sci Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigating regulatory impact: the case of partial price controls on metformin in India.
Ajay Bhaskarabhatla, Chirantan Chatterjee, Priyatam Anurag, Enrico Pennings

Health Policy Plan· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of physicians in prescribing irrational fixed-dose combination medicines in India.
Ajay Bhaskarabhatla, Chirantan Chatterjee

Soc Sci Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The consumer welfare implications of governmental policies and firm strategy in markets for medicines.
Chirantan Chatterjee, Kensuke Kubo, Viswanath Pingali

J Health Econ· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis